Malignant brain tumors are known to utilize acetate as an alternate carbon source in the citric acid cycle for their bioenergetics.
C isotopomer; acetyl-CoA; glutamate and glutamine synthesis; peripheral metabolism 13 C NMR spectroscopy is a powerful method to investigate metabolic pathways in malignant human tumors in vivo using intravenous infusion of nonradioactive 13 C enriched nutrients during the surgical removal of the tumor mass. Previously, it was shown that human glioblastoma (GBM) and metastatic brain tumors were able to oxidize glucose in the citric acid cycle and only a small fraction of glucose carbons was used to derive Abbreviation ACSS2, acetyl-CoA synthetase; C3S, C3 lactate singlet; GBM, glioblastoma; GS, glutamine synthetase; OAA, oxaloacetate; PPP, pentose phosphate pathway; a-KG, a-ketoglutarate.
acetyl-CoA [1, 2] . Recently, using 13 C NMR spectroscopy of surgically resected brain tumor tissues from cancer patients who were infused with [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] acetate, we have identified that acetate acts as a major bioenergetic substrate in GBM and metastatic brain tumors and contributes up to 48.0% AE 4.0 of the acetyl-CoA pool [3] . Acetate-derived acetyl-CoA enters the citric acid cycle via condensation with oxaloacetate (OAA) to form citrate, which further metabolized to form a-ketoglutarate (a-KG) and glutamate [4] . Glutamine is a conditionally essential amino acid that has been shown as a cellular precursor for nucleotide synthesis. Higher glutamine utilization by tumor has been found to support its growth through nucleotide de novo synthesis [5, 6] . In PET imaging, using 18 F-4F-glutamine ( 18 F-FGln), it was demonstrated that gliomas showed higher uptake of glutamine than that of the normal surrounding brain [7] . Human brain tumor expresses glutamine synthetase (GS) which converts glutamate into glutamine [1] [2] [3] . Furthermore, acetate may be metabolized by skeletal muscle, liver and renal tissues to produce key glutamine [5] [6] [7] [8] [9] [10] . Although no net synthesis of glucose from acetate carbons occurs in mammalian liver, [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate influences hepatic gluconeogenesis pathways that leads to 13 C label incorporation into pyruvate, lactate, and glucose in the liver citric acid cycle, which upon entering citric acid cycle in the tumor contributes (via a-ketoglutarate) to glutamate and glutamine pools [8] . Therefore, a comprehensive analysis is required to accurately quantify glutamate and glutamine synthesis in the tumors that includes contributions from circulating 13 C-labeled compounds that are derived from peripheral metabolic activities of [1,2- 13 C]acetate. The purpose of the article was to demonstrate a comprehensive analysis of 13 C turnover of tumor glutamate and glutamine pools under the presence of blood-borne 13 C-labeled glutamine, 13 C-lactate, and 13 C-glucose during the infusion of [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate. This method can be readily applicable to other pathologic and physiologic conditions.
Materials and methods
Infusion of [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate in brain tumor patients Two patients diagnosed with GBM and two patients with metastatic brain tumor (a breast cancer brain metastasis and a nonsmall-cell lung cancer brain metastasis patient) were enrolled to this study following a clinical protocol approved by University of Texas Southwestern Medical Center Institutional Review Board. As described previously, these patients were infused with sterile and pyrogen-free [ Tumor tissue sampling and processing for NMR spectroscopic analysis have been previously described [1] [2] [3] .
NMR Spectroscopy
1 H and 1 H-decoupled carbon ( 13 C) NMR spectra of tumor and plasma extracts were acquired at 600 MHz ( 1 H frequency)/150 MHz ( 13 C frequency) on a Bruker Avance NMR Spectrometer equipped with 10-mm broadband cryogenically cooled probe (Bruker Biospin, Billerica, MA). The NMR spectra of tumor tissues and plasma used in this work have been published [3] . The lactate C3 carbon resonance at 20.8 ppm was used as an internal chemical shift reference. Peak areas of 13 C signals of glutamate and glutamine were measured using ACD software (Advanced Chemistry Development, Toronto, Canada). Amounts of various 13 C-13 C multiplet (doublet, D45; quartet, Q) and singlet (S) peak areas are reported as a fraction normalized to its total carbon resonance area.
13
C enrichment of (Fig. 1A) .
C-isotopomer analysis Results and Discussion C-enrichment of plasma acetate was 88.0 AE 6.0% and its concentration at the end of the infusion period was 1.27 AE 0.22 mM. C. Glutamine synthetase (GS), the key enzyme responsible for the conversion of glutamate to glutamine, is highly expressed in human brain tumors, supporting in situ glutamine synthesis from glutamate [1] [2] [3] 11] . We have observed similar levels of doublets (D45) and quartets (Q) in glutamate and glutamine C4 carbon signals in 13 C NMR spectra of tumor extracts (Figs 3A and 3B) which provide evidence for de novo glutamine synthesis from glutamate in the tumor cells.
C multiplet peak areas of C4 glutamate and glutamine in the tumor are given in Fig. 3C . These peak areas were used to determine fractional contributions of various C4 13 C isotopomers of glutamate and glutamine as described in the methods and are summarized in the Tables 1 and 2 . Previously, we observed the presence of 13 C-labeled glucose and lactate isotopomers in the circulation that were generated due to systemic metabolism of [1,2- C isotopomer (D45) in the plasma of a GBM patient (Fig. 3E) indicates that the presence of 13 C-labeled glutamine in the circulating blood generated due to [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate metabolism by peripheral organs. As illustrated in Fig. 3D , C4 glutamate signals are very weak in the plasma. Plasma C4 glutamine (Fig. 3E (Fig. 3F and Table S1 ). (b) 13 C fractional enrichment of C4 glutamate pool in the tumors was 35.90 AE 11.25% ((b+c+d+e) of tumor C4 GLU in Table 1 ), whereas this value in C4 glutamine was only 28.10 AE 6.44% ((b+c+d+e) of tumor C4 GLN in Table 2 ). If the 13 Cglutamine in the tumor was mainly synthesized from 13 C-glutamate (Tables 1 and 2 ), then the total 13 C fractional enrichment of the C4 carbon of glutamine is expected to be less than or equal to that of its precursor, glutamate C4 carbon, assuming similar pool sizes. Our current results of lower 13 C fractional enrichment of C4 glutamine (Table 2) . Fc2 values used in this study were determined using tumor C4 glutamate D34 doublet peak areas and are given in Table S3 . Through the following mechanisms, [2- Table 2 .
C fractional enrichments of GLN C4 in the tumors. Calculation of a-e are from 13 C NMR spectra of GLN C4 as described in the text (Materials and Methods). d and e correspond to the fractions that have [4,5- Fig. 2 ). Contributions from peripheral metabolism of acetate to overall C4 13 C fractional enrichment of glutamate and glutamine were 6.70% AE 0.02% and 9.08 AE 0.03%, respectively.
Conclusion
In summary, we have illustrated an analysis to determine 13 C turnovers in glutamate and glutamine pools in four brain tumor patients from the infusion of [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate prior to surgical removal of the tumor. This analysis included the contributions from 13 Clabeled nutrients detected in the plasma that originated from systemic metabolism of [1,2- 13 C]acetate.
13
C-glutamine is also detected in the plasma and it was shown to have similar 13 C isotopomer populations of the glutamine present in the tumor tissues. The current analysis revealed that major portion of C4 13 C fractional enrichment of glutamate and glutamine (93.4 AE 0.02% in glutamate and 90.9 AE 0.03% in glutamine) was derived from [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate-derived acetyl-CoA. The analysis described here provides a simple method to quantify the relative contributions from direct utilization of acetate by tumor cells mediated via ACSS2 and peripheral metabolism of [1,2- 13 C]acetate through 13 Clabeled circulating nutrients to 13 C fractional enrichment of glutamate and glutamine pool in the tumor. In addition, the presence of 13 C isotopomers of glucose was utilized to measure relative flux of PPP. This current methodology can be easily extended to similar scenarios for investigating in situ metabolism of other citric acid cycle intermediates and also to other pathologic and physiologic conditions. 
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